Effect of Terminalia arjuna on experimental hyperlipidemia in rabbits

H. P. Shaila, S. L. Udupa, A. L. Udupa, N. S. Nair

Research output: Contribution to journalArticle

Abstract

Hyperlipidemia was induced in rabbits by feeding them cholesterol. The effect of Terminalia arjuna, an indigenous hypolipidemic agent on the serum lipid and lipoprotein profile was studied. Hyperlipidemia produced an increase in cholesterol, VLDL-cholesterol, LDL-cholesterol, triglyceride and reduced the level of HDL-cholesterol. T. arjuna treatment for three months altered the lipoprotein pattern by raising HDL-cholesterol and lowering LDL-cholesterol levels in the drug treated rabbits.

Original languageEnglish
Pages (from-to)126-129
Number of pages4
JournalPharmaceutical Biology
Volume35
Issue number2
DOIs
Publication statusPublished - 01-01-1997
Externally publishedYes

Fingerprint

Terminalia
Hyperlipidemias
LDL Cholesterol
HDL Cholesterol
Lipoproteins
Cholesterol
Rabbits
Hypolipidemic Agents
VLDL Cholesterol
Lipids
Serum
Pharmaceutical Preparations
low density lipoprotein triglyceride

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery
  • Complementary and alternative medicine

Cite this

Shaila, H. P. ; Udupa, S. L. ; Udupa, A. L. ; Nair, N. S. / Effect of Terminalia arjuna on experimental hyperlipidemia in rabbits. In: Pharmaceutical Biology. 1997 ; Vol. 35, No. 2. pp. 126-129.
@article{39a508f2d67c48fab38a17e2ac0bdad4,
title = "Effect of Terminalia arjuna on experimental hyperlipidemia in rabbits",
abstract = "Hyperlipidemia was induced in rabbits by feeding them cholesterol. The effect of Terminalia arjuna, an indigenous hypolipidemic agent on the serum lipid and lipoprotein profile was studied. Hyperlipidemia produced an increase in cholesterol, VLDL-cholesterol, LDL-cholesterol, triglyceride and reduced the level of HDL-cholesterol. T. arjuna treatment for three months altered the lipoprotein pattern by raising HDL-cholesterol and lowering LDL-cholesterol levels in the drug treated rabbits.",
author = "Shaila, {H. P.} and Udupa, {S. L.} and Udupa, {A. L.} and Nair, {N. S.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1076/phbi.35.2.126.13278",
language = "English",
volume = "35",
pages = "126--129",
journal = "Pharmaceutical Biology",
issn = "1388-0209",
publisher = "Informa Healthcare",
number = "2",

}

Effect of Terminalia arjuna on experimental hyperlipidemia in rabbits. / Shaila, H. P.; Udupa, S. L.; Udupa, A. L.; Nair, N. S.

In: Pharmaceutical Biology, Vol. 35, No. 2, 01.01.1997, p. 126-129.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of Terminalia arjuna on experimental hyperlipidemia in rabbits

AU - Shaila, H. P.

AU - Udupa, S. L.

AU - Udupa, A. L.

AU - Nair, N. S.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Hyperlipidemia was induced in rabbits by feeding them cholesterol. The effect of Terminalia arjuna, an indigenous hypolipidemic agent on the serum lipid and lipoprotein profile was studied. Hyperlipidemia produced an increase in cholesterol, VLDL-cholesterol, LDL-cholesterol, triglyceride and reduced the level of HDL-cholesterol. T. arjuna treatment for three months altered the lipoprotein pattern by raising HDL-cholesterol and lowering LDL-cholesterol levels in the drug treated rabbits.

AB - Hyperlipidemia was induced in rabbits by feeding them cholesterol. The effect of Terminalia arjuna, an indigenous hypolipidemic agent on the serum lipid and lipoprotein profile was studied. Hyperlipidemia produced an increase in cholesterol, VLDL-cholesterol, LDL-cholesterol, triglyceride and reduced the level of HDL-cholesterol. T. arjuna treatment for three months altered the lipoprotein pattern by raising HDL-cholesterol and lowering LDL-cholesterol levels in the drug treated rabbits.

UR - http://www.scopus.com/inward/record.url?scp=21544459617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21544459617&partnerID=8YFLogxK

U2 - 10.1076/phbi.35.2.126.13278

DO - 10.1076/phbi.35.2.126.13278

M3 - Article

AN - SCOPUS:21544459617

VL - 35

SP - 126

EP - 129

JO - Pharmaceutical Biology

JF - Pharmaceutical Biology

SN - 1388-0209

IS - 2

ER -